Currently out of the existing stock ratings of Benjamin Burnett, 211 are a BUY (73.01%), 78 are a HOLD (26.99%).

Benjamin Burnett

Work Performance Price Targets & Ratings Chart

Analyst Benjamin Burnett, currently employed at WELLS FARGO, carries an average stock price target met ratio of 47.64% that have a potential upside of 44.4% achieved within 154 days.

Benjamin Burnett’s has documented 547 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on LQDA, Liquidia Technologies at 13-Aug-2026.

Wall Street Analyst Benjamin Burnett

Analyst best performing recommendations are on EFTR (EFFECTOR THERAPEUTICS).
The best stock recommendation documented was for CRSP (CRISPR THERAPEUTICS AG) at 2/13/2025. The price target of $49 was fulfilled within 1 day with a profit of $5.51 (12.67%) receiving and performance score of 126.7.

Average potential price target upside

of $103.1 (58.13%) on NLTX (NEOLEUKIN THERAPEUTICS).
of $39.44 (44.94%) on ATRA (ATARA BIOTHERAPEUTICS).
of $36.14 (118.98%) on GBT (GLOBAL BLOOD THERAPEUTICS).

ALLO Allogene Therapeutics ATRA Atara Biotherapeutics BLUE Bluebird bio CRSP Crispr Therapeutics AG CTIC CTi Biopharma Corp DTIL Precision BioSciences FATE Fate Therapeutics GBT Global Blood Therapeutics IOVA Iovance Biotherapeutics MRTX Mirati Ther NKTR Nektar Therapeutics SGMO Sangamo Therapeutics PGEN Precigen IDYA Ideaya Biosciences RPTX Repare Therapeutics RVMD Revolution Medicines EFTR Effector Therapeutics GNCA Genocea Biosciences NLTX Neoleukin Therapeutics BEAM Beam Therapeutics KNTE Kinnate Biopharma ACLX Arcellx GRCL Gracell Biotechnologies IRON Disc Medicine ALKS Alkermes Plc AVDL Avadel Pharmaceuticals PLC AXSM Axsome Therapeutics CNTA Centessa Pharmaceuticals PLC ADR XENE Xenon Pharmaceuticals WVE Wave Life Sciences Ltd UTHR United Therapeutics INSM Insmed BL Blackline GBTG Global Business Travel Group KN Knowles Cor KROS Keros Therapeutics LQDA Liquidia Technologies MNKD MannKind Corp PRAX Praxis Precision Medicines PTCT PTC Therapeutics RPT RPT Realty CABA Cabaletta Bio RARE Ultragenyx SVRA Savara

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Robert Burns (HC WAINWRIGHT)